131 related articles for article (PubMed ID: 21419474)
61. Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer.
Feng M; Yao G; Yu H; Qing Y; Wang K
BMC Cancer; 2016 Oct; 16(1):794. PubMed ID: 27733135
[TBL] [Abstract][Full Text] [Related]
62. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer.
Cao XY; Ma HX; Shang YH; Jin MS; Kong F; Jia ZF; Cao DH; Wang YP; Suo J; Jiang J
World J Gastroenterol; 2014 Jul; 20(25):8201-8. PubMed ID: 25009393
[TBL] [Abstract][Full Text] [Related]
63. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.
Takehara A; Eguchi H; Ohigashi H; Ishikawa O; Kasugai T; Hosokawa M; Katagiri T; Nakamura Y; Nakagawa H
Cancer Sci; 2006 Nov; 97(11):1191-7. PubMed ID: 16918991
[TBL] [Abstract][Full Text] [Related]
64. Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer.
Eguchi H; Ishikawa O; Ohigashi H; Takahashi H; Yano M; Nishiyama K; Tomita Y; Uehara R; Takehara A; Nakamura Y; Nakagawa H
Pancreas; 2009 Oct; 38(7):791-8. PubMed ID: 19546835
[TBL] [Abstract][Full Text] [Related]
65. Expression of eukaryotic initiation factor 3f is associated with prognosis in gastric carcinomas.
Cheng Y; Jia C; Li G; Li H
Oncol Res Treat; 2014; 37(4):198-202. PubMed ID: 24732644
[TBL] [Abstract][Full Text] [Related]
66. Prognostic value of decreased expression of RBM4 in human gastric cancer.
Yong H; Zhu H; Zhang S; Zhao W; Wang W; Chen C; Ding G; Zhu L; Zhu Z; Liu H; Zhang Y; Wen J; Kang X; Zhu J; Feng Z; Liu B
Sci Rep; 2016 Jun; 6():28222. PubMed ID: 27324405
[TBL] [Abstract][Full Text] [Related]
67. Expression of Activating Protein 4 and Its Relationships with Prognosis in Gastric Cancer.
Sun X; Feng Z; Qu Y; Shao J; Wei N
Chemotherapy; 2017; 62(3):181-186. PubMed ID: 28334723
[TBL] [Abstract][Full Text] [Related]
68. Analyzing Gastric Lavage of Gastric Cancer Patients: A Prospective Observational Study on Cytopathology and Determination of Intragastric CEA, CA 19.9, CA 72.4, and CA 50.
Virgilio E; Giarnieri E; Montagnini M; D''Urso R; Proietti A; Mesiti A; Giovagnoli MR; Mercantini P; Cavallini M; Balducci G
Acta Cytol; 2016; 60(2):161-6. PubMed ID: 27096417
[TBL] [Abstract][Full Text] [Related]
69. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer.
Li Y; Sun H; Guan J; Ji T; Wang X
Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326
[TBL] [Abstract][Full Text] [Related]
70. The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.
Jiang Y; Zhang C; Chen K; Chen Z; Sun Z; Zhang Z; Ding D; Ren S; Zuo Y
PLoS One; 2014; 9(12):e114748. PubMed ID: 25504222
[TBL] [Abstract][Full Text] [Related]
71. Serum levels of intercellular adhesion molecule-1 correlate with advanced and metastatic disease and poor prognosis in gastric cancer.
Polychronidis AC; Tsaroucha AK; Samolis SP; Botaitis SK; Perente SS; Simopoulos CE
Folia Med (Plovdiv); 2003; 45(1):20-4. PubMed ID: 12943063
[TBL] [Abstract][Full Text] [Related]
72. Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay.
Schiedeck TH; Wellm C; Roblick UJ; Broll R; Bruch HP
Dis Colon Rectum; 2003 Jun; 46(6):818-25. PubMed ID: 12794585
[TBL] [Abstract][Full Text] [Related]
73. Overexpression of FIBCD1 Is Predictive of Poor Prognosis in Gastric Cancer.
Jiang C; Zhu J; Zhou P; Zhu H; Wang W; Jin Q; Li P
Am J Clin Pathol; 2018 Apr; 149(6):474-483. PubMed ID: 29659669
[TBL] [Abstract][Full Text] [Related]
74. A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer.
Li W; Jia H; Wang J; Guan H; Li Y; Zhang D; Tang Y; Wang TD; Lu S
Oncotarget; 2017 May; 8(18):30063-30076. PubMed ID: 28415792
[TBL] [Abstract][Full Text] [Related]
75. REG4 independently predicts better prognosis in non-mucinous colorectal cancer.
Kaprio T; Hagström J; Mustonen H; Koskensalo S; Andersson LC; Haglund C
PLoS One; 2014; 9(10):e109600. PubMed ID: 25295732
[TBL] [Abstract][Full Text] [Related]
76. Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.
Chung HW; Lee SG; Kim H; Hong DJ; Chung JB; Stroncek D; Lim JB
J Transl Med; 2009 May; 7():38. PubMed ID: 19476625
[TBL] [Abstract][Full Text] [Related]
77. Serum galectin-3 as a potential marker for gastric cancer.
Cheng D; Liang B; Li Y
Med Sci Monit; 2015 Mar; 21():755-60. PubMed ID: 25765552
[TBL] [Abstract][Full Text] [Related]
78. Mannose receptor as a potential biomarker for gastric cancer: a pilot study.
Liu DR; Guan QL; Gao MT; Jiang L; Kang HX
Int J Biol Markers; 2017 Jul; 32(3):e278-e283. PubMed ID: 28085174
[TBL] [Abstract][Full Text] [Related]
79. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
80. Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer.
Li Y; Guo XB; Wei YH; Kang XL
Clin Transl Oncol; 2021 Jan; 23(1):130-138. PubMed ID: 32500259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
